ABBOTT PARK, Ill., Sept. 22, 2017 /PRNewswire/ -- Abbott (NYSE: ABT) today announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for one of Abbott ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback